Loading clinical trials...
Loading clinical trials...
A Phase 2b Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Adults With Precirrhotic Nonalcoholic Steatohepatitis
Conditions
Interventions
Efinopegdutide
Semaglutide
+1 more
Locations
175
United States
The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 3
Chandler, Arizona, United States
The Institute for Liver Health II dba Arizona Clinical Trials - Peoria ( Site 3289)
Peoria, Arizona, United States
The Institute for Liver Health II dba Arizona Liver Health-Tucson ( Site 3218)
Tucson, Arizona, United States
Del Sol Research Management, LLC ( Site 3211)
Tucson, Arizona, United States
Om Research - Apple Valley ( Site 3244)
Apple Valley, California, United States
Om Research LLC ( Site 3245)
Camarillo, California, United States
Start Date
June 23, 2023
Primary Completion Date
December 29, 2025
Completion Date
December 29, 2025
Last Updated
January 12, 2026
NCT07265544
NCT07403604
NCT06819917
NCT06599918
NCT04681573
NCT07221227
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions